Molecular Determinants for Competitive Inhibition of 4 2 Nicotinic Acetylcholine Receptors
Artículo
Open/ Download
Publication date
2010-06-14Metadata
Show full item record
Cómo citar
Iturriaga-Vásquez, Patricio
Cómo citar
Molecular Determinants for Competitive Inhibition of 4 2 Nicotinic Acetylcholine Receptors
Author
Abstract
The Erythrina alkaloids erysodine and dihydro- -erythroidine
(DH E) are potent and selective competitive inhibitors of
4 2 nicotinic acetylcholine receptors (nAChRs), but little is
known about the molecular determinants of the sensitivity of
this receptor subtype to inhibition by this class of antagonists.
We addressed this issue by examining the effects of
DH E and a range of aromatic Erythrina alkaloids on [3H]cytisine
binding and receptor function in conjunction with homology
models of the 4 2 nAChR, mutagenesis, and functional
assays. The lactone group of DH E and a hydroxyl
group at position C-16 in aromatic Erythrina alkaloids were
identified as major determinants of potency, which was decreased
when the conserved residue Tyr126 in loop A of the
4 subunit was substituted by alanine. Sensitivity to inhibition
was also decreased by substituting the conserved aromatic
residues 4Trp182 (loop B), 4Tyr230 (loop C), and
2Trp82 (loop D) and the nonconserved 2Thr84; however,
only 4Trp182 was predicted to contact bound antagonist,
suggesting 4Tyr230, 2Trp82, and 2Thr84 contribute allosterically
to the closed state elicited by bound antagonist.
In addition, homology modeling predicted strong ionic interactions
between the ammonium center of the Erythrina alkaloids
and 2Asp196, leading to the uncapping of loop C.
Consistent with this, 2D196A abolished sensitivity to inhibition
by DH E or erysodine but not by epierythratidine,
which is not predicted to form ionic bonds with 2Asp196.
This residue is not conserved in subunits that comprise
nAChRs with low sensitivity to inhibition by DH E or erysodine,
which highlights 2Asp196 as a major determinant of
the receptor selectivity of Erythrina alkaloids.
Patrocinador
This work was supported by the National Foundation of Science and Technology
[Grant 11060502]; the Millenium Scientific Initiative [Grant P05-001-
F]; a Oxford Brookes University postgraduate scholarship; a Research Councils
UK Fellowship; the Wellcome Trust [Grant 083547]; the Start-up Project
[DI 2006 INI 06/03-2]; and the Bicentenary Project for Science and Technology,
National Commission for Science and Technology 2004.
Quote Item
Mol Pharmacol, vol. 78, nº 3, p. 366–375, 2010.
Collections